Evidence map›Paper›PMID 40920427›Full record

ArticleMacromolecular bioscience2025

rev-Gelatin: A Gelatin with Reverse Thermo-Responsive Behavior Inspired by Candy and Ice Cubes Phase Dynamics.

Yeongjin Lee, Yu Ri Nam, Keumyeon Kim, Seongyeon Jo, Chanwoo Park, Jeehee Lee, Eunu Kim, Hong Kee Kim, Haeshin Lee

Abstract read
In one paragraph

Article in Macromolecular bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yeongjin LeeDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID 0009-0006-6395-4751
Yu Ri NamDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID 0009-0002-0185-3809
Keumyeon KimR&D Center, SCL Science Inc., Seoul, Republic of Korea.ORCID 0000-0002-0697-5867
Seongyeon JoR&D Center, SCL Science Inc., Seoul, Republic of Korea.
Chanwoo ParkR&BD Center, Genewel Co., Ltd., Seongnam, Republic of Korea.
Jeehee LeeDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID 0000-0001-9480-9633
Eunu KimDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID 0009-0006-8966-8577
Hong Kee KimR&BD Center, Genewel Co., Ltd., Seongnam, Republic of Korea.ORCID 0000-0003-2900-0242
Haeshin LeeDepartment of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.ORCID 0000-0003-3961-9727

Funding

InnoCORE Program of the Ministry of Science and ICT N10250153KAIST Basic Research Program for Professors A0601003029
6 · The paper itself

Abstract

Conventional gelatin's gel-to-sol transition upon heating restricts its utility in biomedical applications that benefit from a gel state at physiological temperatures such as Pluronic F127 and poly(NIPAAm). Herein, we present "rev-Gelatin", a gelatin engineered with reverse thermo-responsive properties that undergoes a sol-to-gel transition as temperature rises from ambient to body temperature. Inspired by the phase dynamics of common materials like candy and ice cubes, whose surfaces soften or partially melt under warming, facilitating inter-object adhesion- rev-Gelatin leverages this concept to achieve fluidity at room temperature for easy injectability. At ambient temperature, rev-Gelatin exists as a microgel solution with sufficient fluidity in the sol state. However, upon exposure to elevated temperatures approaching physiological temperature, rev-Gelatin microgels coalesce through surface melting, forming a stable gel. This sol-to-gel transition is especially advantageous for hemostatic applications. Upon contact with blood, the temperature elevation induces rapid gelation of rev-Gelatin, effectively creating a barrier that reduces bleeding time and blood loss. Additionally, rev-Gelatin shows promise as a submucosal injection agent for gastrointestinal surgeries, making it a new class of thermo-sensitive biomaterials.

Indexed as

GelatinAnimalsHumansIcePhase TransitionPoloxamerTemperatureGelatinIcePoloxamergelatinhemostasisreverse‐directional phase transitionsol‐to‐gel transitionthermo‐responsive

Identifiers

PMID40920427
PMCPMC12704232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.